Oppenheimer Reiterates Outperform on Incyte, Maintains $92 Price Target
Portfolio Pulse from richadhand@benzinga.com
Oppenheimer analyst Jay Olson has reiterated his 'Outperform' rating on Incyte (NASDAQ:INCY) and maintained a price target of $92.
August 04, 2023 | 11:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst has reiterated an 'Outperform' rating on Incyte and maintained a price target of $92.
The reiteration of the 'Outperform' rating and the maintenance of the $92 price target by Oppenheimer analyst Jay Olson indicates a positive outlook for Incyte. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100